Gitte Ebert Petersen
Impact in
- Biotechnology top 10%
- Transgenic Plants and Applications
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
-
- Protein purification and stability 3
- Glycosylation and Glycoproteins Research 1
- Signaling Pathways in Disease 1
- Oncology 6
- Peptidase Inhibition and Analysis 6
- Co-authors
- Conni Lauritzen (7 shared papers)John Pedersen (6 shared papers)José Arnau (6 shared papers)Anne Mølgaard (1 shared paper)Sine Larsen (1 shared paper)Birgitte Munch‐Petersen (1 shared paper)Jure Piškur (1 shared paper)Wolfgang Knecht (1 shared paper)
In The Last Decade
Gitte Ebert Petersen
8 papers receiving 657 citations
Gitte Ebert Petersen's Hit Papers
Peers
Comparison fields: 5 of 82
- Biotechnology 84
- Radiology, Nuclear Medicine and Imaging 162
- Molecular Biology 499
- Oncology 118
- Microbiology 28
Countries citing papers authored by Gitte Ebert Petersen
This map shows the geographic impact of Gitte Ebert Petersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gitte Ebert Petersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gitte Ebert Petersen more than expected).
Fields of papers citing papers by Gitte Ebert Petersen
This network shows the impact of papers produced by Gitte Ebert Petersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gitte Ebert Petersen. The network helps show where Gitte Ebert Petersen may publish in the future.
Co-authors
The 16 scholars most cited alongside Gitte Ebert Petersen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Current strategies for the use of affinity tags and tag removal for the purification of recombinant proteins Hit paper breakdown → | 2005 | 530 |
| 2 | 2007 | 60 | |
| 3 | 2002 | 35 | |
| 4 | 2005 | 31 | |
| 5 | 2006 | 9 | |
| 6 | 2008 | 9 | |
| 7 | 2011 | 6 | |
| 8 | 2011 | 1 |
About Gitte Ebert Petersen
Gitte Ebert Petersen is a scholar working on Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging, Infectious Diseases and Genetics, having authored 8 papers that have together received 681 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (6 papers), Protein purification and stability (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Glycosylation and Glycoproteins Research (1 paper), Enzyme Structure and Function (1 paper), Adenosine and Purinergic Signaling (1 paper), Pneumonia and Respiratory Infections (1 paper) and Signaling Pathways in Disease (1 paper). The work is most often cited by research in Biotechnology (84 citations), Radiology, Nuclear Medicine and Imaging (162 citations), Molecular Biology (499 citations), Oncology (118 citations) and Microbiology (28 citations). Gitte Ebert Petersen has collaborated with scholars based in Denmark, Spain and France. Frequent co-authors include Conni Lauritzen, John Pedersen, José Arnau, Anne Mølgaard, Sine Larsen, Birgitte Munch‐Petersen, Jure Piškur, Wolfgang Knecht, Bo Jensen and Lars Nærum. Their work appears in journals such as Protein Expression and Purification, Biochemical Journal, Bioorganic & Medicinal Chemistry, Journal of Molecular Biology and Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.